By Inkyu Oh | Uihak Shinmun / Ilgan Bosa | Updated March 21, 2026 

Ultrasound medical device specialist Newpong is presenting its full ultrasound technology portfolio, spanning aesthetics, surgery, and therapy, at Booth A713 during KIMES 2026 (Korea International Medical & Hospital Equipment Show). 

The centerpiece of the exhibition is Lincurve, a home HIFU device scheduled for official launch in May and Newpong's first B2C product. Lincurve extends the clinical ultrasound technology developed through the company's hospital-grade device line into the consumer home care market. 

Built on the Concave Technology™ design philosophy used in the clinical Lincurve Pro, Lincurve is engineered to deliver clinic-level lifting results at home. Unlike conventional home beauty devices designed for daily use, Lincurve proposes a usage protocol more akin to clinical practice: one intensive session per month, supplemented by a maintenance session once a week. This structured regimen meaningfully differentiates its positioning in the consumer market. 

 Lincurve

Hospital-Grade Lineup 

The clinical portfolio anchoring Lincurve's technology lineage is also on display at KIMES. 

Lincurve Pro is Newpong's patented, world-first Concave Technology™ HIFU device for hospital use. Unlike conventional flat-cartridge systems, its curved design conforms naturally to the contours of the skin, enabling more uniform and precise delivery of ultrasound energy. The result is a next-generation lifting solution that simultaneously improves procedural efficiency and safety, already generating strong interest in active clinical settings. 

LSSA is a minimally invasive ultrasonic fat-dissolution device equipped with an ultra-thin 0.9 mm-diameter probe, driven by a proprietary ultrasound control algorithm that maintains stable energy delivery and precise fat breakdown. Its clinical application is expanding across both aesthetic and surgical procedures, and the device will be presented at KIMES alongside detailed clinical data. 

In the therapeutic segment, SonoCare is designed for pain relief and tissue regeneration, and has established clinical efficacy in rehabilitation medicine and physical therapy. 

 (from left) LSSA, Lincurve Pro, Sonocare

B2B and B2C: Designed for Synergy, Not Cannibalization 

Prior to KIMES, Newpong extended booth invitations to domestic and international distribution partners and medical institution contacts, receiving strong positive responses from multiple B2B partners. 

The company has been explicit on a point that matters commercially: Lincurve's market entry is structured to create synergy with the existing hospital business, not to cannibalize it. The consumer home care channel is positioned to generate new demand rather than redirect existing B2B volume. 

"Newpong has grown as a company centered on ultrasound medical devices for hospitals and clinics, and we plan to formalize our expansion into the B2C home care market through the Lincurve launch," said a Newpong representative. "Building on the ultrasound technology accumulated in clinical settings, we intend to define a new ultrasound aesthetics market that bridges medicine and home care." 

Full product specifications and technical details for Lincurve are available on the official website. Live device demonstrations are available at Booth A713 throughout KIMES 2026.